Successful surgical treatment of metachronous carcinoma of the appulla of Vater and ductal carcinoma of the distal parts of the pancreas: A case report

Background. Currently, there is a steady trend towards an increase in the incidence of both synchronous and metachronous multiple primary malignant tumors (MPMT). However, metachronous polyneoplasia of the pancreatobiliary tract is relatively rare, and there have been very few reports on successful treatment of this malignancy. Case presentation. In September 2014, the patient K. was diagnosed with adenocarcinoma of the ampulla of Vater (T2N0M0, stage Ib) and underwent gastropancreatoduodenal resection with the creation of pancreatic-gastric anastomosis at the Abdominal Department of Cancer Research Institute of Tomsk National Research Medical Center. There were no complications in the postoperative period. At a 6.5-year followup, no evidence of disease progression was found. In April 2021, a follow-up examination conducted at the Cancer Research Institute revealed a large lesion on the distal part of the pancreatic stump with no clinically significant manifestations. Diagnosis of MPMT was confirmed by transgastric endoscopic ultrasound-guided biopsy. Histological and immunohistochemical examinations revealed undifferentiated ductal carcinoma of the pancreas. Considering the metachronous tumor localization, pancreatic stump extirpation with resection of the posterior wall of the stomach and splenectomy was performed. No complications occurred in the postoperative period. The patient received replacement therapy for exocrine pancreatic insufficiency and individual correction of carbohydrate metabolism. At a 15-month follow-up, liver metastases were detected, and palliative chemotherapy was administered. The patient died 6 months later due to disease progression. The survival time was 99 months after the first surgery and 21 months after the second surgery. Conclusion. We report a rare case of metachronous cancers of the ampulla of Vater and pancreatic stump developed with an interval of 6.5 years. The patient underwent successful curative resections consecutively. The overall survival time from the date of diagnosis was 99 months.

1. Skoropad V.Yu., Berdov B.A., Rukhadze G.O. Polyneoplasia in gastric cancer patients: patterns of development, the results of treatment. Problems in Oncology. 2012; 58(6): 754–761. (in Russian).

2. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209–49. doi: 10.3322/caac.21660.

3. Malignant tumors in Russia in 2023 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2024. 276 p. (in Russian).

4. Malignant tumors in Russia in 2019(morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2020. 252 p. (in Russian).

5. Skoropad V.Yu., Berdov B.A., Kozlov I.G. Metachronic malignant tumors in patients radically operated on gastric cancer. Siberian Journal of Oncology. 2010; (6): 5–11. (in Russian).

6. Amer M.H. Multiple neoplasms, single primaries, and patient survival. Cancer Manag Res. 2014; 5(6): 119–134. doi: 10.2147/CMAR. S57378.

7. Ikeda Y., Saku M., Kawanaka H., Nonaka M., Yoshida K. Features of second primary cancer in patients with gastric cancer. Oncology. 2003; 65(13): 13–117.

8. Ikeguchi M., Ohfuji S., Oka A., Tsujitani S., Maeda M., Kaibara N. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Hepatogastroenterology. 1995; 42: 672–676.

9. Ławniczak M., Gawin A., Jaroszewicz-Heigelmann H., Rogoza-Mateja W., Raszeja-Wyszomirska J., Białek A., Karpińska-Kaczmarczyk K., Starzyńska T. Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study. World J Gastroenterol. 2014 Jun 21; 20(23): 7480–7. doi: 10.3748/wjg.v20.i23.7480.

10. Cheremisina O.V., Menshikov K.Yu., Afanasyev S.G., Vusik M.V. Premalignant lesions and synchronous gastric cancer in patients with lung and head and neck cancer. Siberian Journal of Oncology. 2015; (2): 76–80. (in Russian).

11. Donin N., Filson C., Drakaki A., Tan H.J., Castillo A., Kwan L., Litwin Mark., Chamie K. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016; 122(19): 3075–86. doi: 10.1002/cncr.30164.

12. Moores D., Mane P. Pathology of Primary Tracheobronchial Malignancies Other than Adenoid Cystic Carcinomas.Thorac Surg Clin. 2018 May; 28(2): 149–154. doi: 10.1016/j.thorsurg.2018.01.003.

13. Nyqvist J., Parris T.Z., Helou K., Sarenmalm E.K., Einbeigi Z., Karlsson P., Nasic S., Kovács A. Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018. Breast Cancer Res Treat. 2020; 184(1): 221–228. doi: 10.1007/s10549-020-05822-z.

14. Alhamadh M.S., Alanazi R.B., Algarni S.T., Alhuntushi A.A.R., Alshehri M.Q., Chachar Y.S., Alkaiyat M., Sabatin F. A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience. Curr Oncol. 2022; 29(7): 4941–55. doi: 10.3390/curroncol29070393.

15. Kit O.I., Kolesnikov E.N., Trifanov V.S., Lapteva T.O., Voloshin M.V., Meshcheryakova M.Yu. Metachronous primary-multiple cancer of the head of the pancreas and liver: a case of development of hepatocellular carcinoma 10 years after pancreaticoduodenal resections. Experimental and Clinical Gastroenterology. 2021; 195(11): 79–83. (in Russian). doi: 10.31146/1682-8658-ecg-195-11-79-83

16. Ikematsu Y., Tamura H., Nakata Y., Hayashi T., Kanai T., Hirayama K., Mori H., Ozawa T., Hasegawa S., Okawada T., Kageyama S., Sugimura H., Nishiwaki Y. Metachronous multiple adenocarcinomas of the pancreas. Int J Clin Oncol. 2011 Dec; 16(6): 726–31. doi: 10.1007/s10147-011-0206-6.

17. Patyutko Yu.I., Kotel’nikov A.G., Kudashkin N.E., Polyakov A.N., Moroz E.A., Yastrebova E.V. Major duodenal papilla cancer: treatment and prognosis. Annals of Surgical Hepatology. 2016; 21(4): 84–92. (in Russian).

18. Kim J.H., Kang C.D., Lee K., Lim K.H. Metachronous squamous cell carcinoma of pancreas and stomach in an elderly female patient: A case report. World J Clin Cases. 2021 Nov 6; 9(31): 9680–9685. doi: 10.12998/wjcc.v9.i31.9680.

19. Kato H., Asano Y., Ito M., Arakawa S., Shimura M., Koike D., Kamio K., Kawai T., Urano M., Horiguchi A. A case of metachronous intraductal tubulopapillary carcinoma of the pancreas after surgery for gallbladder cancer-accompanied pancreaticobiliary maljunction. Clin J Gastroenterol. 2022 Oct; 15(5): 1018–1025. doi: 10.1007/s12328-022-01677-7.

20. Minami Y., Hasuike Y., Takeda Y., Tsujinaka T. Metachronous double cancer of the gallbladder and pancreas associated with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 2008; 15(3): 330–3. doi: 10.1007/s00534-007-1208-7.

21. Ishida M., Egawa S., Sakata N., Mikami Y., Motoi F., Abe T., Fukuyama S., Sunamura M., Furukawa T., Unno M. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater’s papilla associated with intraductal papillary-mucinous adenoma. J Hepatobiliary Pancreat Surg. 2007; 14(5): 522–5. doi: 10.1007/s00534-006-1199-9. Epub 2007 Sep 28.

22. Gotoh Y., Ohtsuka T., Nakamura S., Shindo K., Ohuchida K., Miyasaka Y., Mori Y., Mochidome N., Oda Y., Nakamura M. Genetic assessment of recurrent pancreatic high-risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence? Surgery. 2019 Apr; 165(4): 767–774. doi: 10.1016/j.surg.2018.10.025.

23. Eriguchi N., Aoyagi S., Hara M., Okuda K., Tamae T., Fukuda S., Hashino K., Sato S., Fujiki K., Furukawa S., Jimi A. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases. Surg Today. 2000; 30(8): 718–21. doi: 10.1007/s005950070083.

24. Gurmikov B.N., Bolokov M.S., Gurmikova N.L. Longterm results of surgical treatment for pancreatic cancer. A review of the literature. Kuban Scientific Medical Bulletin. 2017; 1(2): 142–147. (in Russian). doi: 10.25207/1608-6228-2017-2-142-147

25. Yastrebova E.V., Kotel’nikov A.G., Patyutko Yu.I., Polikarpova S.B., Moroz E.A., Bazin I.S., Kudashkin N.E. Results of surgical treatment of patients with Papilla Vateri cancer. Medical alphabet. 2018; 2(29): 32–37. (in Russian).

26. Kaminskiy M.N., Kachalov S.N., Ivanov D.V., Rakhimova S.N. Gastric stasis following pancreatoduodenal resection: terminology and prevention issues. Annals of Surgical Hepatology. 2022; 27 (3): 100–107. (in Russian). doi: 10.16931/1995-5464.2022-3-100-107.

27. Oleksenko V.V., Zakharov V.A., Aliev K.A., Bondarev A.V. Al-Nsour J.M. Total pancreatectomy in metachronous primary multiple pancreatic cancer. Tauric Medical-Biological Bulletin. 2022; 25(2): 158–64. (in Russian). doi: 10.37279/2070-8092-2022-25-2-158-164

28. Shabunin A.V., Bedin V.V., Tavobilov M.M., Karpov A.A., Lantsynova A.V., Abramov K.A. Stomach and spleen preserving total pancreatectomy. N.I. Pirogov Russian Journal of Surgery. 2023; 5: 5–12. (in Russian). doi: 10.17116/hirurgia20230515.

29. Szempruch K.R., Walter K., Ebert N., Bridgens K., Desai C.S. Pharmacological management of patients undergoing total pancreatectomy with auto-islet transplantation. Pancreatology. 2022 Jun; 22(5): 656–664. doi: 10.1016/j.pan.2022.04.009.

30. Kubishkin V.A., Kriger A.G., Vishnevskiy V.A., Karmazanovskiy G.G., Kochatkov A.V. Lebedeva A.N., Gorin D.S., Berelavitchus S.V., Zagagov S.O., Filippova E.M. Pancreatectomy for the pancreatic tumors. N.I. Pirogov Russian Journal of Surgery. 2013; 3: 11–16. (in Russian).

31. Ametov A.S., Shabunin A.V., Pashkova E.Yu., Amikishieva K.A., Golodnikov I.I., Tavobilov M.M., Vlasenko A.V., Lukin A.Yu. Management of a patient with diabetes mellitus after total pancreatectomy. Case report. Terapevticheskii Arkhiv (Ter. Arkh.). 2022; 94(10): 1177–1181. doi: 10.2 6442/00403660.2022.10.201882.